Thioguanine for Leukemia

Overview
Thioguanine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute nonlymphocytic leukemias. Thioguanine is often combined with other medications in a chemotherapy regimen. Thioguanine is sold under the brand name Tabloid. Thioguanine may also be referred to as Tioguanine.

Thioguanine is an anticancer drug. Thioguanine is a member of a class of drugs called antimetabolites. Thioguanine is believed to work by interfering with DNA synthesis in replicating cells, thereby inhibiting cancer growth.

How do I take it?
Thioguanine is taken daily by mouth as directed by a doctor.

Thioguanine comes in tablet form.

Side effects
The FDA-approved label for thioguanine lists common side effects including low blood cell counts, nausea, vomiting, loss of appetite, elevated uric acid levels, and mouth sores.

Rare but serious side effects listed for thioguanine include liver damage, fetal harm in pregnant women, and gastrointestinal perforation or necrosis (tissue death).

For more details about this treatment, visit:

Thioguanine — RxList
https://www.rxlist.com/tabloid-drug.htm